HRP20131084T1 - Poboljšana stabilnost topljivosti tableta kalcijeva karbonata - Google Patents

Poboljšana stabilnost topljivosti tableta kalcijeva karbonata Download PDF

Info

Publication number
HRP20131084T1
HRP20131084T1 HRP20131084AT HRP20131084T HRP20131084T1 HR P20131084 T1 HRP20131084 T1 HR P20131084T1 HR P20131084A T HRP20131084A T HR P20131084AT HR P20131084 T HRP20131084 T HR P20131084T HR P20131084 T1 HRP20131084 T1 HR P20131084T1
Authority
HR
Croatia
Prior art keywords
calcium carbonate
tablet
stearic acid
stearate
calcium
Prior art date
Application number
HRP20131084AT
Other languages
English (en)
Croatian (hr)
Inventor
Peder Mohr Olsen
Poul Egon Bertelsen
Thomas Thisted
Henrik Ravn Aage
Original Assignee
Takeda Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Nycomed As filed Critical Takeda Nycomed As
Publication of HRP20131084T1 publication Critical patent/HRP20131084T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HRP20131084AT 2008-11-17 2009-11-17 Poboljšana stabilnost topljivosti tableta kalcijeva karbonata HRP20131084T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08169264 2008-11-17
PCT/EP2009/008157 WO2010054845A1 (en) 2008-11-17 2009-11-17 Improved dissolution stability of calcium carbonate tablets

Publications (1)

Publication Number Publication Date
HRP20131084T1 true HRP20131084T1 (hr) 2013-12-20

Family

ID=40456895

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20131084AT HRP20131084T1 (hr) 2008-11-17 2009-11-17 Poboljšana stabilnost topljivosti tableta kalcijeva karbonata

Country Status (22)

Country Link
US (2) US9101565B2 (enExample)
EP (1) EP2358374B1 (enExample)
JP (1) JP5523467B2 (enExample)
KR (1) KR101807318B1 (enExample)
CN (1) CN102215847B (enExample)
AU (1) AU2009315917B2 (enExample)
BR (1) BRPI0921599B8 (enExample)
CA (1) CA2742449C (enExample)
CY (1) CY1114885T1 (enExample)
DK (1) DK2358374T3 (enExample)
EA (1) EA021707B1 (enExample)
ES (1) ES2437851T3 (enExample)
HR (1) HRP20131084T1 (enExample)
IL (1) IL212442A (enExample)
MX (1) MX2011004744A (enExample)
NZ (1) NZ592528A (enExample)
PL (1) PL2358374T3 (enExample)
PT (1) PT2358374E (enExample)
SI (1) SI2358374T1 (enExample)
SM (1) SMT201400014B (enExample)
WO (1) WO2010054845A1 (enExample)
ZA (1) ZA201103421B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2437851T3 (es) 2008-11-17 2014-01-14 Takeda Nycomed As Comprimidos de carbonato de calcio con estabilidad de disolución mejorada
CA2800266A1 (en) 2010-06-01 2011-12-08 Cargill, Incorporated Orodispersible tablets of erythritol and isomalt
EP3260114A1 (en) 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
CN107281216B (zh) * 2017-06-16 2020-05-05 北京济美堂医药研究有限公司 含钙化合物的药物制剂
CN110575440A (zh) * 2018-06-08 2019-12-17 北京新领先医药科技发展有限公司 一种碳酸钙药物组合物的制备方法
US20220249381A1 (en) 2019-07-05 2022-08-11 TECNIMEDE - Sociedade Técnico-medicinal, SA Compressed macitentan compositions, methods and uses thereof
JP7774867B2 (ja) * 2021-10-04 2025-11-25 備前化成株式会社 食品錠剤の製造方法
JP2025525213A (ja) * 2022-08-04 2025-08-01 シムライズ アーゲー 粉剤または香錠の調製プロセス
KR102675165B1 (ko) * 2023-02-20 2024-06-13 동아제약 주식회사 필름 코팅용 조성물 및 이를 포함하는 필름 코팅액

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115553A (en) * 1973-12-10 1978-09-19 Armour Pharmaceutical Company Antacid tablets
US5204115A (en) 1990-12-12 1993-04-20 Suomen Xyrofin Oy Directly compressible xylitol and method
JP2995226B2 (ja) 1992-03-03 1999-12-27 日本ワイスレダリー株式会社 カルシウム含有チユアブル錠
US5405623A (en) 1993-09-22 1995-04-11 Wm. Wrigley Jr. Company Chewing gum compositions and methods for manufacturing same
DE4427137B4 (de) 1993-10-07 2007-08-23 Degussa Gmbh Fällungskieselsäure
FR2724844B1 (fr) 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
US6716454B2 (en) * 1994-09-23 2004-04-06 Laboratorie Innothera, Société Anonyme Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
US5846506A (en) 1994-10-07 1998-12-08 Degussa Aktiengesellschaft Precipitated silicas
DE19617487A1 (de) 1996-05-02 1997-11-06 Merck Patent Gmbh Geschmacksverbesserung von Arzneimittelwirkstoffen
ATE297191T1 (de) 1996-06-14 2005-06-15 Kyowa Hakko Kogyo Kk Im munde schnellzerfallende tablette
FR2762217B1 (fr) 1997-04-16 2000-09-29 Besins Iscovesco Lab Preparation solide vitamino-calcique, son procede d'obtention et son utilisation
ITFI970184A1 (it) 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
GB9825033D0 (en) 1998-11-13 1999-01-13 Nycomed Pharma As Process
JP2001316249A (ja) 2000-05-11 2001-11-13 Lion Corp 錠剤型医薬組成物
EP1369131A1 (en) 2001-03-06 2003-12-10 Kyowa Hakko Kogyo Co., Ltd. Utilization of spray-dried powder containing sugar alcohol
CA2440361A1 (en) 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co. Ltd. Intraorally rapidly disintegrable preparation
AR034757A1 (es) * 2001-07-16 2004-03-17 Astrazeneca Ab Formulacion farmaceutica que comprende un inhibidor de bomba de protones y antiacidos
ES2192136B1 (es) 2002-01-04 2005-03-16 Italfarmaco, S.A. Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
DE20216314U1 (de) 2002-10-22 2003-12-04 Dhw Deutsche Hydrierwerke Gmbh Rodleben Sprühgetrockneter Xylitol und aus diesem hergestellte Komprimate
EP1753403B1 (en) * 2004-05-24 2014-08-13 Takeda Nycomed AS Particulate comprising a calcium-containing compound and a sugar alcohol
AU2005249175B2 (en) * 2004-06-01 2008-05-08 Takeda As Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
ES2306431T3 (es) * 2005-02-03 2008-11-01 Nycomed Pharma As Granulacion por fusion de una composicion que contiene un compuesto a base de calcio.
UA92052C2 (ru) 2005-12-07 2010-09-27 Нікомед Фарма Ас Предварительно уплотненные кальциесодержащие композиции
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
JP5306229B2 (ja) 2007-01-16 2013-10-02 コーニンクレッカ フィリップス エヌ ヴェ 混合型の指向性端末の装置発見
ES2437851T3 (es) 2008-11-17 2014-01-14 Takeda Nycomed As Comprimidos de carbonato de calcio con estabilidad de disolución mejorada

Also Published As

Publication number Publication date
HK1162354A1 (en) 2012-08-31
EP2358374B1 (en) 2013-09-18
US9999634B2 (en) 2018-06-19
JP5523467B2 (ja) 2014-06-18
CA2742449A1 (en) 2010-05-20
DK2358374T3 (da) 2013-11-11
SI2358374T1 (sl) 2014-01-31
CN102215847A (zh) 2011-10-12
ES2437851T3 (es) 2014-01-14
WO2010054845A1 (en) 2010-05-20
BRPI0921599A2 (pt) 2016-02-10
KR20110086592A (ko) 2011-07-28
PT2358374E (pt) 2013-12-09
PL2358374T3 (pl) 2014-03-31
IL212442A0 (en) 2011-06-30
AU2009315917B2 (en) 2014-11-20
CA2742449C (en) 2018-04-24
SMT201400014B (it) 2014-03-07
IL212442A (en) 2015-10-29
US20110287098A1 (en) 2011-11-24
BRPI0921599B1 (pt) 2020-08-18
CN102215847B (zh) 2014-07-16
EA201170695A1 (ru) 2011-12-30
JP2012508706A (ja) 2012-04-12
EA021707B1 (ru) 2015-08-31
NZ592528A (en) 2013-05-31
US20160022732A1 (en) 2016-01-28
BRPI0921599B8 (pt) 2021-05-25
EP2358374A1 (en) 2011-08-24
KR101807318B1 (ko) 2018-01-10
US9101565B2 (en) 2015-08-11
AU2009315917A1 (en) 2010-05-20
MX2011004744A (es) 2011-05-30
ZA201103421B (en) 2012-10-31
CY1114885T1 (el) 2016-12-14

Similar Documents

Publication Publication Date Title
HRP20131084T1 (hr) Poboljšana stabilnost topljivosti tableta kalcijeva karbonata
HRP20160988T1 (hr) Farmaceutski sastavi s dvostrukim djelovanjem na temelju superstruktura od antagonista/blokatora receptora angiotenzina (arb) i neutralnih inhibitora endopeptidaze (nep)
Late et al. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets
JP2012508706A5 (enExample)
CN101514315B (zh) 一种缓溶型块状清洁剂及其制备方法
HRP20161262T1 (hr) Tablete ulipristal acetata
JP2009529561A5 (enExample)
HRP20120121T1 (hr) Tabletiranje eritritola
KR101788350B1 (ko) 아카보스를 함유하는 경구 붕해 정제
WO2008120181A4 (en) A method of producing fast dissolving tablets
CN101708336A (zh) 一种新型的药用预混辅料
JP7783953B2 (ja) レベチラセタムを含む錠剤
HRP20190550T1 (hr) Formule i metode proizvodnje formulacija za upotrebu u pražnjenju debelog crijeva
RU2013115388A (ru) Смесь отвержденных сахарных спиртов
Kuno et al. Effect of preparation method on properties of orally disintegrating tablets made by phase transition
US9301959B2 (en) Orally dispersible tablet containing compacted sildenafil base
CN107789328B (zh) 一种含有盐酸多奈哌齐的口崩片及其制备方法
WO2012006965A1 (zh) 综合性能改善的片剂及其制备方法
Sudha et al. Modulation of tramadol release from a hydrophobic matrix: implications of formulations and processing variables
RU2005141230A (ru) Фармацевтическая композиция десмопрессина в виде твердой дозированной лекарственной формы и способ ее изготовления
US20070202164A1 (en) Andrographis Extract Formulations
Jaffar et al. Formulation and in vitro evaluation of buccal mucoadhesive tablets of promethazine HCl
Nasreen et al. Mouth dissolving tablets-A unique dosage form curtailed for special purpose: a review
HRP20231170T1 (hr) Proces za proizvodnju tableta jednostavnih za uzimanje sa suhim ekstraktom iz listova ginko bilobe
CN115089554B (zh) 一种盐酸多奈哌齐口腔崩解片及其制备方法